Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

How Are FFI Sweating, Fast Heart Rate, and Fever Managed?

At a Glance

Symptoms such as sweating, a racing heart, and temperature swings in fatal familial insomnia are managed by checking for treatable causes first, then using clinician-guided fluids, comfort measures, carefully selected medicines, and palliative care.

Sweating, a racing heart (tachycardia), and sudden temperature swings can be exhausting and frightening. In fatal familial insomnia (FFI), these are signs of dysautonomia—a condition where the brain structures controlling the autonomic nervous system lose their ability to properly regulate the body’s automatic functions [1]. This leads to a chaotic imbalance between an overactive “fight-or-flight” response and an impaired calming system [2]. Because there is no known cure for FFI, treatment for these symptoms focuses on investigating reversible triggers, providing individualized comfort measures, and utilizing palliative care [3][4].

When to Seek Urgent Help

Sometimes, a racing heart or fever is a warning sign of a life-threatening complication, not just a symptom of FFI [5]. Seek emergency medical care immediately if the patient experiences:

  • Trouble breathing, breathlessness, or chest pain
  • Fainting, severe weakness, or a sudden inability to stay awake
  • A new or worsening state of severe confusion, delirium, or seizures
  • Blue or gray lips
  • An inability to swallow safely or keep fluids down
  • Very little or no urine output (a sign of severe dehydration or kidney distress)

Ruling Out Other Causes

When a patient develops a new fever, a racing heart, or profuse sweating, it is crucial not to automatically assume FFI is the cause [5]. Care teams will first evaluate for other common, treatable triggers [6]:

  • Infections: Infections—including aspiration pneumonia in advanced illness—are possible, treatable causes of fever and tachycardia [7]. Severe infections can lead to sepsis (a dangerous, body-wide response to infection), requiring urgent evaluation [8].
  • Pain and Discomfort: Unrecognized pain, severe constipation, or urinary retention can trigger a surge in heart rate and blood pressure [6].
  • Dehydration and Blood Clots: Severe fluid loss or a pulmonary embolism (a blood clot in the lungs) can manifest as an unexplained fast heart rate [9].
  • Medication Effects: Certain drugs, or the sudden withdrawal of sedatives, can cause severe autonomic instability and sweating [10].

Monitoring and Comfort Measures

If the symptoms are determined to be driven by FFI, management shifts toward supportive care:

  • A Structured Monitoring Plan: Repeatedly checking vital signs can increase anxiety and interfere with sleep. Caregivers should ask the doctor for a simple monitoring plan: what to measure, how often, and what numbers should prompt a call [3]. Keeping a daily log of symptoms, urination, and medications is often more useful than trying to interpret the numbers alone.
  • Fluid and Electrolyte Management: Profuse sweating can cause dangerous fluid loss and abnormal sodium levels in the blood [11]. Both low and high sodium levels are dangerous. Do not force fluids or give over-the-counter salt and electrolyte products without a clinician’s instructions, especially if the patient has impaired swallowing or kidney disease. Fluid and salt replacement must be entirely directed by the clinical team.
  • Temperature Control: While FFI can cause central fevers (temperature dysregulation originating directly from the brain), this is a diagnosis of exclusion; infection must always be ruled out first [7]. For comfort, caregivers can use gentle environmental adjustments like fans, lightweight clothing, and cooling or warming blankets [12]. Avoid extreme heat or direct ice on the skin, check the skin frequently, change damp bedding to prevent irritation, and stop immediately if measures cause shivering or distress.

The Role of Medications

Families sometimes seek targeted medications to control a racing heart or temperature swings. However, there is no FFI-specific evidence proving that autonomic drugs are universally safe or effective for this condition; their use is extrapolated from other disorders [11][13].

  • Beta-blockers: These drugs can slow down a racing heart, but a fast heart rate is sometimes the body’s necessary, compensatory response to dehydration or infection [5]. Giving a beta-blocker before checking for these issues can worsen hypotension (dangerously low blood pressure) or obscure a serious problem [14].
  • Clonidine (and similar drugs): Medications like clonidine can dampen an overactive nervous system, but they carry risks of significant sedation and bradycardia (excessively slow heart rate) [15]. Furthermore, stopping clonidine abruptly can cause a dangerous rebound in blood pressure [16].

Never start, stop, or adjust these medications without the treating clinician’s guidance [17].

Because FFI-related symptoms are so complex, early involvement of neuropalliative care is highly recommended [18]. Neuropalliative care is a specialized type of care for neurological illnesses that focuses on symptom relief, establishing goals of care, and supporting the family [18]. It does not mean giving up on treatment, but rather prioritizing the patient’s comfort and quality of life at every stage.

Common questions in this guide

Why can fatal familial insomnia cause sweating, a fast heart rate, and temperature swings?
These symptoms can reflect dysautonomia, meaning the brain is not regulating automatic body functions normally. A new fever, fast heart rate, or heavy sweating can also come from infection, pain, dehydration, a blood clot, or medication effects, so clinicians should check for reversible causes first.
When should someone with FFI get emergency help for a racing heart or fever?
Get emergency help for trouble breathing or chest pain, fainting, severe weakness, inability to stay awake, new severe confusion, delirium, seizures, blue or gray lips, inability to swallow or keep fluids down, or very little or no urine. These signs may indicate a serious complication such as severe dehydration or infection and should not be assumed to be FFI.
How are sweating and temperature changes managed in fatal familial insomnia?
After treatable causes have been assessed, care usually focuses on individualized comfort measures and clinician-directed fluid and electrolyte management. Fans, lightweight clothing, temperature-adjusted blankets, and dry bedding may help, while extreme heat and direct ice should be avoided.
Can beta-blockers or clonidine treat FFI-related tachycardia?
There is no FFI-specific evidence showing that these medicines are universally safe or effective. A beta-blocker can worsen dangerously low blood pressure if a fast heart rate is responding to dehydration or infection, while clonidine can cause heavy sedation or an overly slow heart rate and may cause a dangerous blood-pressure rise if stopped suddenly. These medicines should be used or changed only with guidance from the treating clinician.
How can caregivers monitor autonomic symptoms safely at home?
Ask the doctor for a simple plan that states what to measure, how often to measure it, and which changes should prompt a call. A daily record of symptoms, urination, fluid intake, and medicines can be more useful than repeatedly checking vital signs, which may increase anxiety and interfere with sleep.
What can neuropalliative care do for a person with FFI?
Neuropalliative care is specialized palliative care for neurological illness. It helps relieve symptoms, clarify goals of care, protect comfort and quality of life, and support the patient and family; it does not mean that all treatment is being stopped.

Get notified when new evidence is published on Fatal familial insomnia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Fatal familial insomnia and Agrypnia Excitata: Autonomic dysfunctions and pathophysiological implications.

    Baldelli L, Provini F

    Autonomic neuroscience : basic & clinical 2019; (218()):68-86 doi:10.1016/j.autneu.2019.02.007.

    PMID: 30890351
  2. 2

    Dysfunction of the cardiac parasympathetic system in fatal familial insomnia: a heart rate variability study.

    Cui Y, Huang Z, Chu M, et al.

    Sleep 2023; (46(4)) doi:10.1093/sleep/zsac294.

    PMID: 36472576
  3. 3

    A case of fatal familial insomnia: diagnostic and therapeutic approaches.

    Rose DK, Liu AJ

    Neurocase 2022; (28(1)):131-134 doi:10.1080/13554794.2021.2025249.

    PMID: 35037601
  4. 4

    [Clinical characteristics and diagnostics of human spongiform encephalopathies: an update].

    Hermann P, Goebel S, Zerr I

    Der Nervenarzt 2024; (95(4)):376-384 doi:10.1007/s00115-024-01644-2.

    PMID: 38503894
  5. 5

    Tackling the Treachery of Tachycardia.

    Tewelde SZ, Adjei S

    Emergency medicine clinics of North America 2026; (44(2)):309-314 doi:10.1016/j.emc.2026.01.001.

    PMID: 41895880
  6. 6

    Challenges in Treatment of Inappropriate Sinus Tachycardia.

    Ruzieh M, Moustafa A, Sabbagh E, et al.

    Current cardiology reviews 2018; (14(1)):42-44 doi:10.2174/1573403X13666171129183826.

    PMID: 29189171
  7. 7

    Fatal insomnia: the elusive prion disease.

    Patel D, Ibrahim H, Rankin J, et al.

    BMJ case reports 2021; (14(6)) doi:10.1136/bcr-2020-241289.

    PMID: 34158325
  8. 8

    Creutzfeldt-Jakob Disease and Fatal Familial Insomnia: Demographics and In-Hospital Mortality in Spain.

    Cuadrado-Corrales N, Lopez-de-Andres A, Hernández-Barrera V, et al.

    Journal of clinical medicine 2024; (13(15)) doi:10.3390/jcm13154401.

    PMID: 39124670
  9. 9

    Asymptomatic tachycardia and acute pulmonary embolism in a case of tuberculosis spondylodiscitis.

    Ahmedy F, Ahmad Fauzi A, Engkasan JP

    Spinal cord series and cases 2018; (4()):43 doi:10.1038/s41394-018-0074-7.

    PMID: 29844926
  10. 10

    Recognising and differentiating paroxysmal sympathetic hyperactivity after severe traumatic brain injury: a practical diagnostic approach.

    Abdullah MW

    Acta neurologica Belgica 2026; doi:10.1007/s13760-026-03176-9.

    PMID: 42622998
  11. 11

    Fatal familial insomnia: A new case description with response to thoracic sympathetic nerve thermocoagulation and stellate ganglion block.

    Chen Y, Li Y, Zhou Y, et al.

    Sleep medicine 2025; (127()):24-27 doi:10.1016/j.sleep.2024.12.034.

    PMID: 39765140
  12. 12

    Paroxysmal Sympathetic Hyperactivity After Acquired Brain Injury: An Integrative Review of Diagnostic and Management Challenges.

    Xu SY, Zhang Q, Li CX

    Neurology and therapy 2024; (13(1)):11-20 doi:10.1007/s40120-023-00561-x.

    PMID: 37948005
  13. 13

    Clinical Practice: Should we Radically Alter our Sedation of Critical Care Patients, Especially Given the COVID-19 Pandemics?

    Longrois D, Petitjeans F, Simonet O, et al.

    Romanian journal of anaesthesia and intensive care 2020; (27(2)):43-76 doi:10.2478/rjaic-2020-0018.

    PMID: 34056133
  14. 14

    Efficacy of medical and ablation therapy for inappropriate sinus tachycardia: A single-center experience.

    Shabtaie SA, Witt CM, Asirvatham SJ

    Journal of cardiovascular electrophysiology 2021; (32(4)):1053-1061 doi:10.1111/jce.14942.

    PMID: 33566447
  15. 15

    Low-dose clonidine infusion to improve sleep in postoperative patients in the high-dependency unit. A randomised placebo-controlled single-centre trial.

    Liu D, Hallt E, Platz A, et al.

    Intensive care medicine 2024; (50(11)):1873-1883 doi:10.1007/s00134-024-07619-w.

    PMID: 39311905
  16. 16

    Evaluation and Pharmacologic Management of Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury.

    Ott JL, Watanabe TK

    The Journal of head trauma rehabilitation 2024; (39(6)):E576-E581 doi:10.1097/HTR.0000000000000960.

    PMID: 38833717
  17. 17

    Non-Pharmacological and Pharmacological Management of Cardiac Dysautonomia Syndromes.

    Y Lei L, S Chew D, K Sandhu R, et al.

    Journal of atrial fibrillation 2020; (13(1)):2395 doi:10.4022/jafib.2395.

    PMID: 33024496
  18. 18

    From parasomnia to agrypnia excitata - An illustrative case on diagnostic approach.

    Fong SL, Dy Closas AMF, Lim TT, et al.

    Parkinsonism & related disorders 2023; (109()):105332 doi:10.1016/j.parkreldis.2023.105332.

    PMID: 36948111

This page is for informational purposes only and does not constitute medical advice. It explains comfort and symptom-management considerations in fatal familial insomnia; consult the treating team before changing fluids, monitoring, or medicines, and seek urgent care for warning signs.